Fig. 1From: Indirect comparison of glucagon like peptide-1 receptor agonists regarding cardiovascular safety and mortality in patients with type 2 diabetes mellitus: network meta-analysisNetwork meta-analysis results of GLP1RAs and placebo using fixed effect modelBack to article page